|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-earning deposits with financial institutions | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest-earning time deposits in other financial institutions | ||||||||||||||||||||
| Securities: | ||||||||||||||||||||
| Available for sale | ||||||||||||||||||||
| Held to maturity (fair value of $4,920 and $4,948 at March 31, 2025 and December 31, 2024) | ||||||||||||||||||||
| Available for sale (amortized cost of $428,022 and $426,145 at June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Held to maturity (fair value of $4,078 and $4,103 at June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Real estate | ||||||||||||||||||||
| Commercial and other | ||||||||||||||||||||
| Unaccreted discount on acquired loans | ||||||||||||||||||||
| Held for Investment Loans | ||||||||||||||||||||
| Total unaccreted discount on acquired loans | ||||||||||||||||||||
| Deferred loan costs, net | ||||||||||||||||||||
| Held for Investment Loans | ||||||||||||||||||||
| Total deferred loan costs, net | ||||||||||||||||||||
| Loans held for investment, net of deferred loan costs and unaccreted discounts on acquired loans | ||||||||||||||||||||
| Held for Investment Loans | ||||||||||||||||||||
| Total loans held for investment, net of deferred loan costs and unaccreted discounts on acquired loans | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Held for Investment Loans | ||||||||||||||||||||
| Total loans held for investment | ||||||||||||||||||||
| Allowance for loan losses | ||||||||||||||||||||
| Held for Investment Loans | ||||||||||||||||||||
| Total allowance for loan losses | ||||||||||||||||||||
| Loans held for investment, net of allowance for loan losses | ||||||||||||||||||||
| Held for Investment Loans | ||||||||||||||||||||
| Total loans held for investment, net of allowance for loan losses | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Federal Home Loan Bank (FHLB) stock | ||||||||||||||||||||
| Equity Securities | ||||||||||||||||||||
| Net deferred tax assets | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Cash surrender value of bank owned life insurance (BOLI) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Servicing assets | ||||||||||||||||||||
| Core deposit intangibles | ||||||||||||||||||||
| Right-of-use assets - operating leases | ||||||||||||||||||||
| Accrued interest and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing demand | ||||||||||||||||||||
| Savings, NOW and money market accounts | ||||||||||||||||||||
| Time deposits $250,000 and under | ||||||||||||||||||||
| Time deposits over $250,000 | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Reserve for unfunded commitments | ||||||||||||||||||||
| FHLB advances | ||||||||||||||||||||
| Long-term debt, net of issuance costs | ||||||||||||||||||||
| Subordinated debentures, net | ||||||||||||||||||||
| Lease liabilities - operating leases | ||||||||||||||||||||
| Accrued interest and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred Stock - 100,000,000 shares authorized, no par value; none outstanding | ||||||||||||||||||||
| Common Stock - 100,000,000 shares authorized, no par value; 16,985,919 shares issued and outstanding at June 30, 2026 and 17,057,397 shares issued and outstanding at December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
